LFMD LIFEMD INC

LifeMD and HealthWarehouse.com Partner in Exclusive Telehealth Agreement

LifeMD and HealthWarehouse.com Partner in Exclusive Telehealth Agreement

NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: LFMD), a leading provider of virtual primary care services, today announced that it has entered into an agreement to be the exclusive telehealth provider for  (OTC: HEWA).

The partnership between the two companies will enable HealthWarehouse.com to offer virtual treatment to over one million existing patients and make available real-time consultations to potential new patients purchasing pharmacy products from their online health marketplace. LifeMD’s 50-state affiliated medical group, composed of outstanding full-time doctors and nurse practitioners, provides convenient access to engage with a licensed medical provider and receive high-quality, personalized treatment.

“LifeMD’s mission is built on the premise that everyone should be able to access exceptional healthcare when and where they need it by removing the complexities that get between the patient and quality treatment,” said Justin Schreiber, Chairman & CEO of LifeMD. “We are excited that this partnership with HealthWarehouse.com will empower an even larger population to easily access patient-first clinicians and receive, if appropriate, fairly priced prescription products.”

is a leading digital pharmacy, shipping FDA-approved prescription medication, over-the-counter products, and veterinary medication directly to customers nationwide. Centrally located in the Greater Cincinnati/Northern Kentucky area, HealthWarehouse.com ships to 80% of the U.S. population within 2-3 days. Its focus on technology, sourcing, and operational efficiency allows HealthWarehouse.com to pass along significant savings and affordable healthcare to customers.

Joseph Peters, President and CEO of HealthWarehouse.com, commented, “The partnership with LifeMD directly supports our focus on offering better technology to attract and retain customers. We pride ourselves in providing the highest quality of care. This new ability to offer same-day consultations with—if appropriate—prescription approvals, ensures rapid access to high-quality treatment and necessary products, enabling our customers to live healthier lives.”

About LifeMD

LifeMD is a leading provider of virtual primary care. The Company offers telemedicine, laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s health, women’s health, allergy & asthma, and dermatology. Leveraging a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a US-based patient care center, LifeMD is simplifying healthcare by increasing access to top-notch and affordable care. For more information, please visit .

Media Contact

Investor Contact

Marc Benathen, CFO

About HealthWarehouse.com

HealthWarehouse.com, Inc. (OTCQB: HEWA), a technology company with a focus on healthcare e-commerce, sells and delivers prescription medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards of Pharmacy (NABP). HealthWarehouse.com provides a platform focused on increasing access and reducing costs of healthcare products for consumers nationwide. Based in Florence, Kentucky, the Company operates America's Leading Online Pharmacy and a pioneer in affordable healthcare. As one of the first National Association of Boards of Pharmacy (“NABP”) Approved Digital Pharmacies, HealthWarehouse.com services the mission of providing affordable healthcare and incredible patient services to help Americans. Learn more at .

Contact

Joseph Peters, President and CEO

(800)748-7001



EN
08/05/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LIFEMD INC

 PRESS RELEASE

LifeMD Reports Fourth Quarter and Full Year 2025 Results

LifeMD Reports Fourth Quarter and Full Year 2025 Results Full year 2025 revenue grew 25% to $194.1 million; adjusted EBITDA rose 309% to $15.3 million.Fourth quarter revenue increased 4% to $46.9 million; adjusted EBITDA rose 348% to $4.8 million.Successfully launched oral Wegovy subsequent to year end, with over 80% of new weight management patients initiating branded therapy and Q1 sign-ups at record levels.Exited 2025 with $36.8 million of cash and no debt, positioning LifeMD for accelerated investments in growth.Benefits infrastructure on track to cover approximately 220 million America...

 PRESS RELEASE

LifeMD to Participate in Two Investor Conferences During March

LifeMD to Participate in Two Investor Conferences During March NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of March: Mizuho Securities Healthcare Technology Conference 2026, March 5. Management will hold virtual one-on-one meetings with investors throughout the day.KeyBanc Capital Markets Healthcare Forum, March 17-18. Management will participate in a virtual fireside chat on Wednesday, March 18th at 9:00 a.m. ...

 PRESS RELEASE

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9 NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and 12 months ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time. Conference Call & Webcast Details Date:Monday, March 9thTime:4:30 p.m. Eastern timeToll-Free Dial-In:800-343-5172International Dial-In:203-518-9856Conference ID:LIFEMDLive & Archiv...

 PRESS RELEASE

LifeMD Announces Closing of $50 Million Revolving Credit Facility with...

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A. NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced the closing of a new senior secured revolving credit facility (“RCF”) with Citizens Bank, N.A. (“Citizens”). The facility has a maturity date of January 2, 2029 and provides for up to $50 million of total availability consisting of $30 million of committed availability with an additional accordion option of up to $20 million. As of closing, no balance was dra...

 PRESS RELEASE

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealt...

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill Adds first and only FDA‑approved oral GLP‑1 to its virtual weight management offering, expanding access to affordable, branded treatment options NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced it is Novo Nordisk’s Wegovy® (semaglutide) pill – the first and only FDA-approved oral GLP-1 therapy for chronic weight management and cardiovascular health – through its end-to-end teleh...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch